612 related articles for article (PubMed ID: 33548031)
1. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng Y; Faber KN; de Meijer VE; Blokzijl H; Moshage H
Hepatol Int; 2021 Feb; 15(1):21-35. PubMed ID: 33548031
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
3. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria.
Amorim R; Magalhães CC; Borges F; Oliveira PJ; Teixeira J
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106795
[TBL] [Abstract][Full Text] [Related]
4. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
5. Metabolic drivers of non-alcoholic fatty liver disease.
Bence KK; Birnbaum MJ
Mol Metab; 2021 Aug; 50():101143. PubMed ID: 33346069
[TBL] [Abstract][Full Text] [Related]
6. Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes.
Hong SH; Hong Y; Lee M; Keum BR; Kim GH
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986221
[TBL] [Abstract][Full Text] [Related]
7. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis.
Hughey CC; Puchalska P; Crawford PA
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159209. PubMed ID: 35934297
[TBL] [Abstract][Full Text] [Related]
8. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD).
Flessa CM; Kyrou I; Nasiri-Ansari N; Kaltsas G; Kassi E; Randeva HS
J Cell Biochem; 2022 Oct; 123(10):1585-1606. PubMed ID: 35490371
[TBL] [Abstract][Full Text] [Related]
10. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
11. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.
Bellanti F; Villani R; Tamborra R; Blonda M; Iannelli G; di Bello G; Facciorusso A; Poli G; Iuliano L; Avolio C; Vendemiale G; Serviddio G
Redox Biol; 2018 May; 15():86-96. PubMed ID: 29220698
[TBL] [Abstract][Full Text] [Related]
14. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
Peng KY; Watt MJ; Rensen S; Greve JW; Huynh K; Jayawardana KS; Meikle PJ; Meex RCR
J Lipid Res; 2018 Oct; 59(10):1977-1986. PubMed ID: 30042157
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.
Leamy AK; Egnatchik RA; Young JD
Prog Lipid Res; 2013 Jan; 52(1):165-74. PubMed ID: 23178552
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
Ipsen DH; Lykkesfeldt J; Tveden-Nyborg P
Cell Mol Life Sci; 2018 Sep; 75(18):3313-3327. PubMed ID: 29936596
[TBL] [Abstract][Full Text] [Related]
18. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
19. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
Pierantonelli I; Svegliati-Baroni G
Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
